Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0WB0R
|
|||
| Drug Name |
KPP203
|
|||
| Indication | Subacute cutaneous lupus erythematosus [ICD-11: EB50; ICD-10: L93.1] | Phase 2 | [1] | |
| Company |
Novartis PharmaceuticalsEast Hanover, NJ
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Sphingosine-1 phosphate receptor (S1PR) | Target Info | Agonist | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.